These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3545428)

  • 61. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation.
    Shaw PJ; Bergin ME; Burgess MA; Dalla Pozza L; Kellie SJ; Rowell G; Stevens MM; Webster BH; Bradstock KF
    J Clin Oncol; 1994 Oct; 12(10):2138-45. PubMed ID: 7931485
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation.
    Sierra J; Brunet S; Grañena A; Olivé T; Bueno J; Ribera JM; Petit J; Besses C; Llorente A; Guardia R; Macía J; Rovira M; Badell I; Vela E; Díaz de Heredia C; Vivancos P; Carreras E; Feliu E; Montserrat E; Julía A; Cubells J; Rozman C; Domingo A; Ortega JJ
    J Clin Oncol; 1996 Apr; 14(4):1353-63. PubMed ID: 8648394
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
    Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
    Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine.
    Jones RB; Matthes S; Shpall EJ; Fisher JH; Stemmer SM; Dufton C; Stephens JK; Bearman SI
    J Natl Cancer Inst; 1993 Apr; 85(8):640-7. PubMed ID: 8468721
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.
    Brochstein JA; Kernan NA; Groshen S; Cirrincione C; Shank B; Emanuel D; Laver J; O'Reilly RJ
    N Engl J Med; 1987 Dec; 317(26):1618-24. PubMed ID: 3317056
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
    Michel G; Gluckman E; Esperou-Bourdeau H; Reiffers J; Pico JL; Bordigoni P; Thuret I; Blaise D; Bernaudin F; Jouet JP
    J Clin Oncol; 1994 Jun; 12(6):1217-22. PubMed ID: 8201385
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependent.
    Muus P; Donnelly P; Schattenberg A; Linssen P; Minderman H; Dompeling E; de Witte T
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):47-52. PubMed ID: 8290971
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy.
    Zander AR; Dicke KA; Keating M; Vellekoop L; Culbert S; Spitzer G; Kanojia M; Jagannath S; Schell S; Hester J
    Cancer; 1985 Sep; 56(6):1374-9. PubMed ID: 3896457
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparison.
    Appelbaum FR; Dahlberg S; Thomas ED; Buckner CD; Cheever MA; Clift RA; Crowley J; Deeg HJ; Fefer A; Greenberg PD
    Ann Intern Med; 1984 Nov; 101(5):581-8. PubMed ID: 6385797
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: excessive hepatic toxicity.
    Jones RB; Shpall EJ; Ross M; Coniglio D; Affronti ML; Peters WP
    Cancer Chemother Pharmacol; 1990; 26(2):155-6. PubMed ID: 2189592
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse.
    Appelbaum FR; Clift RA; Buckner CD; Stewart P; Storb R; Sullivan KM; Thomas ED
    Blood; 1983 May; 61(5):949-53. PubMed ID: 6338977
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Therapeutic progress--review XXVII. High dose chemotherapy in haematological malignancy.
    Hamon MD; Donohue SM; Franklin IM
    J Clin Pharm Ther; 1987 Aug; 12(4):203-11. PubMed ID: 3305528
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bone marrow transplantation with high-dose cytosine arabinoside.
    Herzig RH; Lazarus HM; Graham-Pole J; Gross S; Coccia P; Gordon EM; Strandjord S; Phillips GL; Herzig GP
    Med Pediatr Oncol; 1982; 10 Suppl 1():235-8. PubMed ID: 6761567
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Leukemia relapse after allogeneic bone marrow transplantation: a review.
    Giralt SA; Champlin RE
    Blood; 1994 Dec; 84(11):3603-12. PubMed ID: 7949117
    [No Abstract]   [Full Text] [Related]  

  • 77. Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases.
    Mitchell RB; Wagner JE; Karp JE; Watson AJ; Brusilow SW; Przepiorka D; Storb R; Santos GW; Burke PJ; Saral R
    Am J Med; 1988 Nov; 85(5):662-7. PubMed ID: 3189370
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical evaluation of cyclophosphamide. A new agent for the treatment of children with acute leukemia.
    FERNBACH DJ; SUTOW WW; THURMAN WG; VIETTI TJ
    JAMA; 1962 Oct; 182():30-7. PubMed ID: 13892445
    [No Abstract]   [Full Text] [Related]  

  • 79. Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag.
    Anwer F; Yun S; Nair A; Ahmad Y; Krishnadashan R; Deeg HJ
    Case Rep Hematol; 2015; 2015():583451. PubMed ID: 26180646
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Etoposide and teniposide in the treatment of acute leukemia.
    Björkholm M
    Med Oncol Tumor Pharmacother; 1990; 7(1):3-10. PubMed ID: 2187120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.